300
Participants
Start Date
July 7, 2023
Primary Completion Date
March 31, 2025
Study Completion Date
June 30, 2025
EDITOR (CBOT with olfactory stimulants, OFC tasks & remote monitoring of treatment compliance)
EDITOR includes a user-friendly cloud portal synced with the main device, providing a comprehensive training program for the orbitofrontal cortex (OFC). The main device stimulates the orbitofrontal cortex intensely, preventing habituation to smells and improving adaptability. This enhances neurobehavioral plasticity, benefiting Substance Use Disorder (SUD) outcomes. The device also features a 60% beta-caryophyllene scent for addressing issues like Alcohol Use Disorder and stimulant use disorders. With ten digital enhancements, it enables remote treatment and data collection, seamlessly transmitting information to healthcare providers through a secure, HIPAA-compliant portal.
CBOT with olfactory stimulants & OFC tasks
The CBOT with proprietary odorant molecules is designed to stimulate olfactory neural activity over long periods of time combined with orbitofrontal cortex (OFC) dependent olfactory tasks.
CBOT Sham
CBOT Sham uses artificially scented compressed room air instead of olfactory stimulants and has control cognitive olfactory tasks
RECRUITING
Clinics of Dr. Edwin Chapman @ MHDG, Washington D.C.
RECRUITING
Howard University, Washington D.C.
ENROLLING_BY_INVITATION
Maryland Treatment Center, Rockville
Howard University
OTHER
Maryland Treatment Center
UNKNOWN
Clinics of Dr. Edwin Chapman, MD, PC @ MHDG
UNKNOWN
National Institute on Drug Abuse (NIDA)
NIH
Evon Medics LLC
INDUSTRY